GRAIL
Generated by Meeveem AI
"Pioneering multi-cancer early detection to save lives through blood-based screening technology."
Menlo Park, CA
•501 - 1000 Employees
•Diagnostics
About GRAIL
GRAIL develops the Galleri test, a blood-based screening that detects cancer signals before symptoms appear. The test screens for over 50 cancer types, including many deadly forms that lack recommended screening today. Using advanced sequencing, machine learning, and population-scale clinical studies, GRAIL enables earlier intervention when treatment may be more effective. The company addresses a critical gap in healthcare. Most cancers are detected late, when outcomes are poor. GRAIL empowers individuals, employers, insurers, and health systems to catch cancer earlier. This proactive tool shifts cancer care from reactive treatment to early intervention, potentially saving lives across communities worldwide.
910
Team Members
2016
Founded
Diagnostics
Sector
Hybrid
Work Environment
Our Vision
A world where cancer is detected early enough to be cured, eliminating the global burden of late stage diagnoses and transforming cancer from a deadly disease into a manageable condition caught before symptoms emerge.
Our Mission
At GRAIL, our mission is to detect cancer early, when it can be cured.